ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

Abstract

Among phenotypically similar patients with angina with nonobstructive coronary arteries, only those with an impaired CFR derive benefit from anti-ischemic therapy. These findings support measurement of CFR to diagnose and guide management of this otherwise heterogeneous patient group.